Allergan Seeks Opportunities To Dominate In Key Therapeutic Areas

Allergan plc is known as one of the most acquisitive players in the pharmaceutical industry, but the company asserted its commitment to in-house and early-stage innovation as well during R&D Day presentations on Nov. 4, reflecting a strategy similar to its potential acquirer Pfizer Inc.